Pictet Asset Management Holding SA »

Compass Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2026-03-31 $76k 14k 5.29

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Amazon (AMZN)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Thermo Fisher Scientific (TMO)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Nextera Energy (NEE)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Ecolab (ECL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
BVF
Vanguard Capital Management
State Street Corporation
Adage Capital Partners GP
Deerfield Management Company
Geode Capital Management
Blue Owl Capital Holdings
Rock Springs Capital Management

View all funds holding Compass Therapeutics